Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobie de Villiers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2015
In memoriam: Stephen Hough 27/08/1947-05/12/2014Tobie de Villiers
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 18, 2002
Hormone replacement therapy--a dilemmaErnst W W Sonnendecker, Tobie de Villiers
Climacteric : the Journal of the International Menopause Society|June 27, 2024
The road to Melbourne (take two)Tim Hillard, Rod Baber, Tobie de Villiers
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 22, 2004
Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosisStephen Hough, Brynne Ascott-Evans, Tobie de Villiers, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 3, 2013
Improved management of patients with osteoporosisStephen Hough, Sue Brown, Bilkish Cassim, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 6, 2003
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetatePatrick Neven, Tore Lunde, Pierluigi Benedetti-Panici, et al.
Expert Opinion on Biological Therapy|July 23, 2025
A randomized, double blind, parallel design, repeat dose, 2-arm, multicenter study comparing the efficacy, safety, immunogenicity, and pharmacokinetic profiles of a denosumab biosimilar, AVT03, in postmenopausal women with osteoporosisMamuka Lortkipanidze, Tobie de Villiers, Grzegorz Kania, et al.
Journal of Bone Oncology|April 18, 2017
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGPeyman Hadji, Matti S Aapro, Jean-Jacques Body, et al.
Climacteric : the Journal of the International Menopause Society|October 23, 2004
Practical recommendations for hormone replacement therapy in the peri- and postmenopauseHenry Burger, David Archer, David Barlow, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2015
In memoriam: Stephen Hough 27/08/1947-05/12/2014Tobie de Villiers
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 18, 2002
Hormone replacement therapy--a dilemmaErnst W W Sonnendecker, Tobie de Villiers
Climacteric : the Journal of the International Menopause Society|June 27, 2024
The road to Melbourne (take two)Tim Hillard, Rod Baber, Tobie de Villiers
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 22, 2004
Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosisStephen Hough, Brynne Ascott-Evans, Tobie de Villiers, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 3, 2013
Improved management of patients with osteoporosisStephen Hough, Sue Brown, Bilkish Cassim, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 6, 2003
A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetatePatrick Neven, Tore Lunde, Pierluigi Benedetti-Panici, et al.
Expert Opinion on Biological Therapy|July 23, 2025
A randomized, double blind, parallel design, repeat dose, 2-arm, multicenter study comparing the efficacy, safety, immunogenicity, and pharmacokinetic profiles of a denosumab biosimilar, AVT03, in postmenopausal women with osteoporosisMamuka Lortkipanidze, Tobie de Villiers, Grzegorz Kania, et al.
Journal of Bone Oncology|April 18, 2017
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGPeyman Hadji, Matti S Aapro, Jean-Jacques Body, et al.
Climacteric : the Journal of the International Menopause Society|October 23, 2004
Practical recommendations for hormone replacement therapy in the peri- and postmenopauseHenry Burger, David Archer, David Barlow, et al.
Pageof 1